El-Shemi AG
ORCID: 0000-0002-4772-8416
· 1 paper in corpus
2015
Pegylated-interferon-α based therapy for the treatment of chronic hepatitis C (CHC) is considered suboptimal as not all patients respond to the treatment and it is associated with several side effects that could lead to dose reduction and/o…